InvestorsHub Logo
Followers 20
Posts 5354
Boards Moderated 0
Alias Born 01/04/2012

Re: None

Sunday, 09/03/2023 5:26:04 AM

Sunday, September 03, 2023 5:26:04 AM

Post# of 14917
Someone more well versed in patent litigation may wish to jump in here. As I understand it, it looks like the Patent Examiner is ready to grant Novitium the patent for Hydrochlorothiazide Compositions, once they deal with the double patenting reasoning for the final rejection. According to the conclusion of the Final Rejection it looks like they need to reconcile their first patent application (parent) with this application to overcome the rejection. Simply filing a Terminal Disclaimer for the Parent patent application # 17/546,175 would render the rejection moot paving the way for their next submission to be approved.

The document can be accessed through the link below. Select Documents and Transactions, then go to the be conclusion of the Final Rejection.


Patent Application
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ANIP News